These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2515040)

  • 1. Correlation between growth curves and killing curves of Escherichia coli in the presence of fleroxacin and ampicillin.
    Yourassowsky E; Van der Linden MP; Crokaert F
    Chemotherapy; 1989; 35(6):423-30. PubMed ID: 2515040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro.
    Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J
    Chemotherapy; 1996; 42(5):354-62. PubMed ID: 8874975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sub-minimal inhibitory concentrations of ciprofloxacin and fleroxacin on the bacterial capsular antigen and opsonophagocytosis by human polymorphonuclear leukocytes.
    Keller N; Raponi G; Hoepelman IM; Overbeek BP; Rozenberg-Arska M; Verhoef J
    Zentralbl Bakteriol; 1991 Jan; 274(4):519-26. PubMed ID: 1907453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The killing action of fleroxacin upon Bacteroides fragilis.
    Griggs DJ; Piddock LJ; Wise R
    J Antimicrob Chemother; 1989 Jan; 23(1):53-8. PubMed ID: 2501268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
    Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
    Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between growth curve and killing curve of Escherichia coli after a brief exposure to suprainhibitory concentrations of ampicillin and piperacillin.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    Antimicrob Agents Chemother; 1985 Dec; 28(6):756-60. PubMed ID: 3909953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect on growth curve patterns of brief exposure of bacteria to different concentrations of beta-lactam antibiotics.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():27-36. PubMed ID: 3920184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal kinetics of various dosages of fleroxacin simulated in bacterial cultures.
    Bauernfeind A; Eberlein E; Hörl G
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():81-9. PubMed ID: 3144553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
    Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA
    Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of fleroxacin and ofloxacin in experimental pyelonephritis.
    Ritzerfeld W
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():119-22. PubMed ID: 3144529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of quinolones against slowly growing bacteria.
    Dalhoff A; Matutat S; Ullmann U
    Chemotherapy; 1995; 41(2):92-9. PubMed ID: 7758362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of method, medium, pH and inoculum on the in-vitro antibacterial activities of fleroxacin and norfloxacin.
    Hohl P; Felber AM
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():71-80. PubMed ID: 3144552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16.
    Lewin CS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):83-6. PubMed ID: 1693968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative activities of norfloxacin and fleroxacin in experimental infections due to Salmonella typhimurium and Escherichia coli.
    Hof H; Fabrig J
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():123-7. PubMed ID: 3144530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coli.
    Rescott DL; Nix DE; Holden P; Schentag JJ
    Antimicrob Agents Chemother; 1988 Apr; 32(4):450-3. PubMed ID: 3288112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of fleroxacin against Chlamydia trachomatis.
    Steele-Mortimer O; Meier-Ewert H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():65-70. PubMed ID: 3144551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic activity in microbiological media versus that in human urine: comparison of ampicillin, ciprofloxacin, and trimethoprim-sulfamethoxazole.
    Drobot GR; Karlowsky JA; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 1996 Jan; 40(1):237-40. PubMed ID: 8787914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro studies of fleroxacin (Ro 23-6240), a new trifluorinated quinolone derivative.
    Digranes A; Benonisen E; Salveson A; Zahm F
    Chemotherapy; 1988; 34(5):401-10. PubMed ID: 3141116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single Cell Killing Kinetics Differentiate Phenotypic Bacterial Responses to Different Antibacterial Classes.
    Zhang Y; Kepiro I; Ryadnov MG; Pagliara S
    Microbiol Spectr; 2023 Feb; 11(1):e0366722. PubMed ID: 36651776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.